Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 23

1.

Cell circuits between B cell progenitors and IL-7+ mesenchymal progenitor cells control B cell development.

Fistonich C, Zehentmeier S, Bednarski JJ, Miao R, Schjerven H, Sleckman BP, Pereira JP.

J Exp Med. 2018 Oct 1;215(10):2586-2599. doi: 10.1084/jem.20180778. Epub 2018 Aug 29.

PMID:
30158115
2.

Author Correction: Metabolic gatekeeper function of B-lymphoid transcription factors.

Chan LN, Chen Z, Braas D, Lee JW, Xiao G, Geng H, Cosgun KN, Hurtz C, Shojaee S, Cazzaniga V, Schjerven H, Ernst T, Hochhaus A, Kornblau SM, Konopleva M, Pufall MA, Cazzaniga G, Liu GJ, Milne TA, Koeffler HP, Ross TS, Sánchez-García I, Borkhardt A, Yamamoto KR, Dickins RA, Graeber TG, Müschen M.

Nature. 2018 Jun;558(7711):E5. doi: 10.1038/s41586-018-0164-5.

3.

A kindred with mutant IKAROS and autoimmunity.

Van Nieuwenhove E, Garcia-Perez JE, Helsen C, Rodriguez PD, van Schouwenburg PA, Dooley J, Schlenner S, van der Burg M, Verhoeyen E, Gijsbers R, Frietze S, Schjerven H, Meyts I, Claessens F, Humblet-Baron S, Wouters C, Liston A.

J Allergy Clin Immunol. 2018 Aug;142(2):699-702.e12. doi: 10.1016/j.jaci.2018.04.008. Epub 2018 Apr 27. No abstract available.

PMID:
29705243
4.

The Aryl Hydrocarbon Receptor Preferentially Marks and Promotes Gut Regulatory T Cells.

Ye J, Qiu J, Bostick JW, Ueda A, Schjerven H, Li S, Jobin C, Chen ZE, Zhou L.

Cell Rep. 2017 Nov 21;21(8):2277-2290. doi: 10.1016/j.celrep.2017.10.114.

5.

Antagonism of B cell enhancer networks by STAT5 drives leukemia and poor patient survival.

Katerndahl CDS, Heltemes-Harris LM, Willette MJL, Henzler CM, Frietze S, Yang R, Schjerven H, Silverstein KAT, Ramsey LB, Hubbard G, Wells AD, Kuiper RP, Scheijen B, van Leeuwen FN, Müschen M, Kornblau SM, Farrar MA.

Nat Immunol. 2017 Jun;18(6):694-704. doi: 10.1038/ni.3716. Epub 2017 Apr 3.

6.

Metabolic gatekeeper function of B-lymphoid transcription factors.

Chan LN, Chen Z, Braas D, Lee JW, Xiao G, Geng H, Cosgun KN, Hurtz C, Shojaee S, Cazzaniga V, Schjerven H, Ernst T, Hochhaus A, Kornblau SM, Konopleva M, Pufall MA, Cazzaniga G, Liu GJ, Milne TA, Koeffler HP, Ross TS, Sánchez-García I, Borkhardt A, Yamamoto KR, Dickins RA, Graeber TG, Müschen M.

Nature. 2017 Feb 23;542(7642):479-483. doi: 10.1038/nature21076. Epub 2017 Feb 13. Erratum in: Nature. 2018 Jun;558(7711):E5.

7.

Genetic analysis of Ikaros target genes and tumor suppressor function in BCR-ABL1+ pre-B ALL.

Schjerven H, Ayongaba EF, Aghajanirefah A, McLaughlin J, Cheng D, Geng H, Boyd JR, Eggesbø LM, Lindeman I, Heath JL, Park E, Witte ON, Smale ST, Frietze S, Müschen M.

J Exp Med. 2017 Mar 6;214(3):793-814. doi: 10.1084/jem.20160049. Epub 2017 Feb 11.

8.

Ikaros Inhibits Group 3 Innate Lymphoid Cell Development and Function by Suppressing the Aryl Hydrocarbon Receptor Pathway.

Li S, Heller JJ, Bostick JW, Lee A, Schjerven H, Kastner P, Chan S, Chen ZE, Zhou L.

Immunity. 2016 Jul 19;45(1):185-97. doi: 10.1016/j.immuni.2016.06.027.

9.

Regulation of gene expression dynamics during developmental transitions by the Ikaros transcription factor.

Arenzana TL, Schjerven H, Smale ST.

Genes Dev. 2015 Sep 1;29(17):1801-16. doi: 10.1101/gad.266999.115. Epub 2015 Aug 27.

10.

Targeting casein kinase II restores Ikaros tumor suppressor activity and demonstrates therapeutic efficacy in high-risk leukemia.

Song C, Gowda C, Pan X, Ding Y, Tong Y, Tan BH, Wang H, Muthusami S, Ge Z, Sachdev M, Amin SG, Desai D, Gowda K, Gowda R, Robertson GP, Schjerven H, Muschen M, Payne KJ, Dovat S.

Blood. 2015 Oct 8;126(15):1813-22. doi: 10.1182/blood-2015-06-651505. Epub 2015 Jul 28.

11.

Identification of FOXM1 as a therapeutic target in B-cell lineage acute lymphoblastic leukaemia.

Buchner M, Park E, Geng H, Klemm L, Flach J, Passegué E, Schjerven H, Melnick A, Paietta E, Kopanja D, Raychaudhuri P, Müschen M.

Nat Commun. 2015 Mar 10;6:6471. doi: 10.1038/ncomms7471.

12.

Restriction of IL-22-producing T cell responses and differential regulation of regulatory T cell compartments by zinc finger transcription factor Ikaros.

Heller JJ, Schjerven H, Li S, Lee A, Qiu J, Chen ZM, Smale ST, Zhou L.

J Immunol. 2014 Oct 15;193(8):3934-46. doi: 10.4049/jimmunol.1401234. Epub 2014 Sep 5.

13.

Selective regulation of lymphopoiesis and leukemogenesis by individual zinc fingers of Ikaros.

Schjerven H, McLaughlin J, Arenzana TL, Frietze S, Cheng D, Wadsworth SE, Lawson GW, Bensinger SJ, Farnham PJ, Witte ON, Smale ST.

Nat Immunol. 2013 Oct;14(10):1073-83. doi: 10.1038/ni.2707. Epub 2013 Sep 8.

14.

Regulation of B cell fate commitment and immunoglobulin heavy-chain gene rearrangements by Ikaros.

Reynaud D, Demarco IA, Reddy KL, Schjerven H, Bertolino E, Chen Z, Smale ST, Winandy S, Singh H.

Nat Immunol. 2008 Aug;9(8):927-36. doi: 10.1038/ni.1626. Epub 2008 Jun 22.

15.

Regulation of the polymeric Ig receptor by signaling through TLRs 3 and 4: linking innate and adaptive immune responses.

Schneeman TA, Bruno ME, Schjerven H, Johansen FE, Chady L, Kaetzel CS.

J Immunol. 2005 Jul 1;175(1):376-84.

16.

De novo synthesized RelB mediates TNF-induced up-regulation of the human polymeric Ig receptor.

Schjerven H, Tran TN, Brandtzaeg P, Johansen FE.

J Immunol. 2004 Aug 1;173(3):1849-57.

17.

Proinflammatory cytokines upregulate expression of calprotectin (L1 protein, MRP-8/MRP-14) in cultured human keratinocytes.

Mørk G, Schjerven H, Mangschau L, Søyland E, Brandtzaeg P.

Br J Dermatol. 2003 Sep;149(3):484-91.

PMID:
14510979
20.
21.

Mannuronan C-5-epimerases and their application for in vitro and in vivo design of new alginates useful in biotechnology.

Ertesvåg H, Høidal HK, Schjerven H, Svanem BI, Valla S.

Metab Eng. 1999 Jul;1(3):262-9.

PMID:
10937941
22.

Regulation of the formation and external transport of secretory immunoglobulins.

Norderhaug IN, Johansen FE, Schjerven H, Brandtzaeg P.

Crit Rev Immunol. 1999;19(5-6):481-508. Review.

PMID:
10647747
23.

E2F-mediated growth regulation requires transcription factor cooperation.

van Ginkel PR, Hsiao KM, Schjerven H, Farnham PJ.

J Biol Chem. 1997 Jul 18;272(29):18367-74.

Supplemental Content

Loading ...
Support Center